FDA clears first smartphone app for controlling insulin delivery

Published



The Food and Drug Administration approved the first smartphone app designed to help with insulin delivery.

Tandem Diabetes Care announced on Wednesday that the FDA cleared its t:connect mobile app for use. The app allows users to control bolus insulin delivery through the t:slim X2 insulin pump.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.